Transscleral Cyclophotocoagulation for Refractory Intraocular Pressure Elevation after Penetrating Keratoplasty.

IF 2 4区 医学 Q2 OPHTHALMOLOGY
Cristina Martin Lesan, Elias Flockerzi, Ursula Löw, Berthold Seitz
{"title":"Transscleral Cyclophotocoagulation for Refractory Intraocular Pressure Elevation after Penetrating Keratoplasty.","authors":"Cristina Martin Lesan, Elias Flockerzi, Ursula Löw, Berthold Seitz","doi":"10.1097/IJG.0000000000002562","DOIUrl":null,"url":null,"abstract":"<p><strong>Prcis: </strong>Transscleral cyclophotocoagulation significantly reduces intraocular pressure and antiglaucomatous medication use post-penetrating keratoplasty, with low hypotony risk, particularly if delayed. Safe reintervention is feasible for intraocular pressure recurrence.</p><p><strong>Purpose: </strong>Transscleral cyclophotocoagulation (TSCPC) is an established procedure for lowering intraocular pressure (IOP). We aimed to evaluate the therapeutic efficacy and the safety of TSCPC in patients with refractory IOP elevation after penetrating keratoplasty (PK), as well as to identify risk factors associated with postoperative hypotony.</p><p><strong>Patients and methods: </strong>TSCPC was performed in 52 eyes with inadequate pressure regulation despite maximal conservative therapy after PK. All the patients were reviewed at day one, one month, six months and one year after the TSCPC. A diagnosis of hypotony was considered if the IOP was lower than 6 mmHg at any time postoperatively. Multivariate analysis was applied to identify risk factors for hypotony and elevated IOP recurrence.</p><p><strong>Results: </strong>The IOP value decreased significantly from the median baseline of 29.1±0.7 mmHg to 15.1±0.8 mmHg at one year follow-up. The number of antiglaucomatous medications was significantly reduced one year after TSCPC (2.9±0.1 vs. 2.4±0.2; P<0.01). Only six (11.5%) patients developed transitory hypotony. The mean time between PK and TSCPC was significantly lower (P<0.01) in patients who developed hypotony (5.8±2.2 mo vs. 28.9±5.7 mo). 53.8% of cases had a relapse of IOP increase at any time point during the follow-up. Reintervention with TSCPC was performed in 42.4% of patients.</p><p><strong>Conclusion: </strong>TSCPC after PK reduces significantly IOP and the number of antiglaucomatous medications. The rate of postoperative hypotony is low. Patients with shorter time interval between PK and TSCPC are at higher risk of developing hypotony. TSCPC can be safely reperformed in patients after PK.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Glaucoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IJG.0000000000002562","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Prcis: Transscleral cyclophotocoagulation significantly reduces intraocular pressure and antiglaucomatous medication use post-penetrating keratoplasty, with low hypotony risk, particularly if delayed. Safe reintervention is feasible for intraocular pressure recurrence.

Purpose: Transscleral cyclophotocoagulation (TSCPC) is an established procedure for lowering intraocular pressure (IOP). We aimed to evaluate the therapeutic efficacy and the safety of TSCPC in patients with refractory IOP elevation after penetrating keratoplasty (PK), as well as to identify risk factors associated with postoperative hypotony.

Patients and methods: TSCPC was performed in 52 eyes with inadequate pressure regulation despite maximal conservative therapy after PK. All the patients were reviewed at day one, one month, six months and one year after the TSCPC. A diagnosis of hypotony was considered if the IOP was lower than 6 mmHg at any time postoperatively. Multivariate analysis was applied to identify risk factors for hypotony and elevated IOP recurrence.

Results: The IOP value decreased significantly from the median baseline of 29.1±0.7 mmHg to 15.1±0.8 mmHg at one year follow-up. The number of antiglaucomatous medications was significantly reduced one year after TSCPC (2.9±0.1 vs. 2.4±0.2; P<0.01). Only six (11.5%) patients developed transitory hypotony. The mean time between PK and TSCPC was significantly lower (P<0.01) in patients who developed hypotony (5.8±2.2 mo vs. 28.9±5.7 mo). 53.8% of cases had a relapse of IOP increase at any time point during the follow-up. Reintervention with TSCPC was performed in 42.4% of patients.

Conclusion: TSCPC after PK reduces significantly IOP and the number of antiglaucomatous medications. The rate of postoperative hypotony is low. Patients with shorter time interval between PK and TSCPC are at higher risk of developing hypotony. TSCPC can be safely reperformed in patients after PK.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Glaucoma
Journal of Glaucoma 医学-眼科学
CiteScore
4.20
自引率
10.00%
发文量
330
审稿时长
4-8 weeks
期刊介绍: The Journal of Glaucoma is a peer reviewed journal addressing the spectrum of issues affecting definition, diagnosis, and management of glaucoma and providing a forum for lively and stimulating discussion of clinical, scientific, and socioeconomic factors affecting care of glaucoma patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信